Evidence map›Paper›PMID 35244215›Full record

ArticleInternational journal of cosmetic science2022

Exploring compounds to be used as cosmetic agents that activate peroxisome proliferator-activated receptor alpha.

Keisuke Tachibana, Syohei Fukuda, Jun Fukushima, Kenji Ishimoto, Masahiro Sakata, Yasutomo Nishimori, Takefumi Doi

Open access · greenAbstract read
In one paragraph

Article in International journal of cosmetic science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Keisuke TachibanaGraduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.ORCID https://orcid.org/0000-0003-0044-8772
Syohei FukudaGraduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.
Jun FukushimaGraduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.
Kenji IshimotoGraduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.
Masahiro SakataMaruho Co., Ltd., Kanagawa, Japan.
Yasutomo NishimoriMaruho Co., Ltd., Osaka, Japan.
Takefumi DoiGraduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.
Osaka University of Pharmaceutical Sciences · JPMaruho (Japan) · JP

Funding

Japan Agency for Medical Research and Development AMED-BINDS/JP21am0101084Japan Agency for Medical Research and Development AMED-BINDS/JP21am0101085Japan Agency for Medical Research and Development AMED-BINDS/JP21am0101123Japan Society for the Promotion of Science KAKENHI/15H02896Japan Society for the Promotion of Science KAKENHI/18H03190Japan Society for the Promotion of Science KAKENHI/21H03354
6 · The paper itself

Abstract

objectiveThe human epidermis is formed by the proliferation and differentiation of keratinocytes adjacent to the basement membrane. The outermost layer, the stratum corneum, is equipped with a barrier function that prevents water evaporation, and intercellular lipids play an important role in this barrier function. When the barrier is functioning normally, evaporation is prevented; however, when barrier function is impaired, moisture evaporates, resulting in dry and rough skin. Therefore, maintenance of normal barrier function is critical for maintaining normal skin function. Peroxisome proliferator-activated receptor α (PPARα) is mainly not only involved in lipid metabolism in the liver but is also expressed in the epidermis and is involved in inducing keratinocyte differentiation, promoting lipid production, maintaining barrier function and suppressing skin inflammation. Hence, compounds that activate PPARα are expected to control skin function. Therefore, we identified PPARα activators from among extracts of natural resources that have been approved for use in humans and analysed the effects of these extracts on skin function.

methodsFirst, extracts of 474 natural resources were screened using a PPARα activator screening cell line independently constructed in our laboratory. Next, reporter assays were performed using the Gal4-chimera system to evaluate whether these extracts act as ligands for PPARα. We then analysed their effect on primary normal human epidermal keratinocyte cells by using real-time RT-PCR. Finally, we evaluated PPARα activation effect by the combination of these extracts.

resultsWe identified 36 extracts having the effect of activating PPARα. In particular, #419, a Typha angustifolia spike extract, showed concentration-dependent transcriptional activation through PPARα-LBD and was considered to be likely to contain a compound that is a ligand of PPARα. #419 increased the expression of PPARα target genes and genes related to skin function in primary cultured human epidermal keratinocytes. Finally, the use of #419 in combination with nine extracts increased PPAR activity more than twice as much as #419 alone treatment.

conclusionsThese results showed that the reporter cell line could be useful for discovering extracts of natural resources and that the identified Typha angustifolia spike extract could be used in cosmetics that activate PPARα, which expected to improve skin function.

Indexed as

CosmeticsPPAR alphaHumansKeratinocytesLigandsPlant ExtractsSkinCosmeticsLigandsPlant ExtractsPPAR alphacosmetic materialsgenetic analysiskeratinocytePPARαskin barrierskin physiologyTypha angustifolia

Identifiers

PMID35244215
PMCPMC9321093
OpenAlexW4214864914

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.